Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implications

Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implications

Metabolic dysfunction-associated fatty liver disease (MAFLD) encompasses a spectrum of liver diseases ranging from metabolic dysfunction-associated fatty liver to metabolic dysfunction-associated steatohepatitis, which may progress to liver cirrhosis and hepatocellular carcinoma. Several mechanisms,...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuwei Hu, Yingjie Ai, Chencheng Hu, Fathima N. Cassim Bawa, Yanyong Xu
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2025-05-01
Series:Genes and Diseases
Subjects:
Apoptosis
Fibrosis
Inflammation
MAFLD
Steatosis
Transcription factors
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304224001697
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items